Garrison Bradford & Associates Inc Bristol Myers Squibb CO Transaction History

Garrison Bradford & Associates Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 09, 2021	SELL	$57.74 - $65.43 $230,960 - $261,720	-4,000 Closed	0 $0
Q3 2019 Nov 05, 2019	BUY	$42.77 - $50.71 $171,080 - $202,840	4,000 New	4,000 $203,000
Q1 2019 May 01, 2019	SELL	$45.12 - $53.8 $180,480 - $215,200	-4,000 Closed	0 $0
Q3 2017 Nov 09, 2017	BUY	$55.23 - $63.74 $220,920 - $254,960	4,000	4,000 $255,000

2,403

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $114B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Garrison Bradford & Associates Inc, based on Form 13F filings with the SEC.

Stay updated on Garrison Bradford & Associates Inc with notifications on news.